Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
TRAINING-Ovary 01 (connecTed pRehabiliAtIoN pelvIc caNcer surGery): multicenter randomized study comparing neoadjuvant chemotherapy for patients managed for ovarian cancer with or without a connected pre-habilitation program.
Lambaudie E, Bannier/Braticevic C, Villaron/Goetgheluck C, Zemmour C, Boher JM, Ben Soussan P, Pakradouni J, Brun C, Lopez Almeida L, Marino P. Lambaudie E, et al. Among authors: lopez almeida l. Int J Gynecol Cancer. 2021 Jun;31(6):920-924. doi: 10.1136/ijgc-2020-002128. Epub 2020 Dec 1. Int J Gynecol Cancer. 2021. PMID: 33262113 Free article. Clinical Trial.
Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer.
Lynce F, Valenza C, Niman SM, Bertucci F, Kai M, Ryan S, Troll E, Layman RM, Fanucci KA, Giordano A, Nasrazadani A, Nakhlis F, Bellon J, Warren L, Block C, Schumer S, Lucci A, Krishnamurthy S, Trapani D, Lerebours F, Dalenc F, Levy C, Petit T, Leheurteur M, Bachelot T, Tredan O, Ribeiro JM, Pistilli B, Zagami P, Ladoire S, Lopez Almeida L, Zemmour C, Carey LA, Tolaney SM, Valero V; MDACC Inflammatory Breast Cancer Team; Curigliano G, Regan MM, Goncalves A, Woodward WA. Lynce F, et al. Among authors: lopez almeida l. ESMO Open. 2026 Feb;11(2):106050. doi: 10.1016/j.esmoop.2025.106050. Epub 2026 Jan 19. ESMO Open. 2026. PMID: 41558201 Free PMC article.
Does Breast Surgery Type Alter Incidental Axillary Irradiation? A Dosimetric Analysis of the "Sentinel Envahi et Randomisation du Curage" SERC Trial.
Nicolas C, Petit C, Tallet A, Boher JM, Varela Cagetti L, Favrel V, Gonzague Casabianca L, Guenole M, Mailleux H, Darreon J, Bannier M, Cohen M, Sabiani L, Tallet C, Teyssandier C, Gonçalves A, De Nonneville A, Lopez Almeida L, Coste N, Tyran M, Houvenaeghel G. Nicolas C, et al. Among authors: lopez almeida l. Cancers (Basel). 2024 Mar 19;16(6):1198. doi: 10.3390/cancers16061198. Cancers (Basel). 2024. PMID: 38539532 Free PMC article.
A phase II study of lenalidomide and rituximab (R2) combination in patients with high-risk refractory/relapsed diffuse large B-cell lymphoma.
Noel R, Zemmour C, Montes de Oca C, Belmecheri N, Aurran-Schleinitz T, Coso D, Lopez Almeida L, Mescam L, Vey N, Bladé JS, Slama B, Bouabdallah R, Schiano de Colella JM. Noel R, et al. Among authors: lopez almeida l. Hematology. 2023 Dec;28(1):2207948. doi: 10.1080/16078454.2023.2207948. Hematology. 2023. PMID: 37133334 Free article. Clinical Trial.
Impact of fiducial markers placement on the delineation of target volumes in radiation therapy for oesophageal cancer: FIDUCOR study.
Rochigneux P, Tyran M, Autret A, Lopez Almeida L, Guiramand J, Ferre M, Chanez B, Mitry E, Ratone JP, Giovannini M, Tallet A, Moureau-Zabotto L, Caillol F. Rochigneux P, et al. Among authors: lopez almeida l. Front Oncol. 2022 Oct 28;12:1012712. doi: 10.3389/fonc.2022.1012712. eCollection 2022. Front Oncol. 2022. PMID: 36387207 Free PMC article.